Arca
Skip to content

C5AR1: C5a anaphylatoxin chemotactic receptor 1

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a, stimulating chemotaxis, granule enzyme release, intracellular calcium release and superoxide anion production.

  • Drugs that act on it: 2
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
AvacopanApprovedC5a anaphylatoxin chemotactic receptor antagonistAntagonist—
Avdoralimab—C5a anaphylatoxin chemotactic receptor inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Nephritis
0.30
Rapidly progressive glomerulonephritis
0.26
Cancer
0.13
Neoplasm
0.13
Alzheimer disease
0.11
Sepsis
0.11

Drugs and mechanisms are from ChEMBL CHEMBL2373 (CC BY-SA 3.0). Gene name, function (UniProt P21730, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.